Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. C Type Natriuretic Peptide
2. C Type Natriuretic Peptide 22
3. C Type Natriuretic Peptide 53
4. C-type Natriuretic Peptide
5. C-type Natriuretic Peptide-22
6. C-type Natriuretic Peptide-53
7. Cnp-22
8. Cnp-53
9. Natriuretic Peptide, C Type
10. Natriuretic Peptide-22, C-type
11. Natriuretic Peptide-53, C-type
12. Peptide, C-type Natriuretic
13. Peptide-22, C-type Natriuretic
14. Peptide-53, C-type Natriuretic
1. 127869-51-6
2. C-type Natriuretic Peptide (32-53) (human, Porcine, Rat)
3. C-type Natriuretic Peptide (cnp) (1-22), Human
4. Atriopeptin C (pig)
5. Natriuretic Peptide,c-type
6. Cnp (1-22), Human
7. Unii-3vcd78874l
8. Cnp-53
9. Dtxsid60155686
10. 3vcd78874l
11. Bdbm287915
12. Us10087144, Compound Cnp
13. Akos024457659
14. Natriuretic Peptide, C-type, >=95% (hplc)
15. C-type Natriuretic Peptide (1-22) (human, Rat, Swine)
16. C-type Natriuretic Peptide (32-53) (human, Porcine, Rat) Acetate Salt
17. Natriuretic Peptide, C-type, Human And Porcine - Cas 127869-51-6
18. C-type Natriuretic Peptide (cnp) (1-22), Humanc-type Natriuretic Peptide (cnp) (1-22), Human
19. H-gly-leu-ser-lys-gly-cys-phe-gly-leu-lys-leu-asp-arg-ile-gly-ser-met-ser-gly-leu-gly-cys-oh
| Molecular Weight | 2197.6 g/mol |
|---|---|
| Molecular Formula | C93H157N27O28S3 |
| XLogP3 | -8.7 |
| Hydrogen Bond Donor Count | 32 |
| Hydrogen Bond Acceptor Count | 35 |
| Rotatable Bond Count | 44 |
| Exact Mass | 2196.0853510 g/mol |
| Monoisotopic Mass | 2196.0853510 g/mol |
| Topological Polar Surface Area | 962 Ų |
| Heavy Atom Count | 151 |
| Formal Charge | 0 |
| Complexity | 4490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 17 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Natriuretic Agents
Endogenous or exogenous chemicals that regulate the WATER-ELECTROLYTE BALANCE in the body. They consist of peptides and non-peptide compounds. (See all compounds classified as Natriuretic Agents.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
97
PharmaCompass offers a list of Natriuretic Peptide, C-Type API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Natriuretic Peptide, C-Type manufacturer or Natriuretic Peptide, C-Type supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Natriuretic Peptide, C-Type manufacturer or Natriuretic Peptide, C-Type supplier.
PharmaCompass also assists you with knowing the Natriuretic Peptide, C-Type API Price utilized in the formulation of products. Natriuretic Peptide, C-Type API Price is not always fixed or binding as the Natriuretic Peptide, C-Type Price is obtained through a variety of data sources. The Natriuretic Peptide, C-Type Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CNP-22 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CNP-22, including repackagers and relabelers. The FDA regulates CNP-22 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CNP-22 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CNP-22 supplier is an individual or a company that provides CNP-22 active pharmaceutical ingredient (API) or CNP-22 finished formulations upon request. The CNP-22 suppliers may include CNP-22 API manufacturers, exporters, distributors and traders.
CNP-22 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CNP-22 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CNP-22 GMP manufacturer or CNP-22 GMP API supplier for your needs.
A CNP-22 CoA (Certificate of Analysis) is a formal document that attests to CNP-22's compliance with CNP-22 specifications and serves as a tool for batch-level quality control.
CNP-22 CoA mostly includes findings from lab analyses of a specific batch. For each CNP-22 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CNP-22 may be tested according to a variety of international standards, such as European Pharmacopoeia (CNP-22 EP), CNP-22 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CNP-22 USP).
